Future trends for patient-specific dosimetry methodology in molecular radiotherapy
Physica Medica · 2023-11 · 115 · 103165
DOI: 10.1016/j.ejmp.2023.103165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physica Medica, 2023-11. Verfasst von Johan Gustafsson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Radiation Physics, Lund, Lund University, Lund, Sweden. Electronic address: johan_ruben.gustafsson@med.lu.se. Hauptthemen laut MEDLINE: Radiometry, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Institute of Cancer Research, Swedish Cancer Society.
Abstract (Originalsprache)
Molecular radiotherapy is rapidly expanding, and new radiotherapeutics are emerging. The majority of treatments is still performed using empirical fixed activities and not tailored for individual patients. Molecular radiotherapy dosimetry is often seen as a promising candidate that would allow personalisation of treatments as outcome should ultimately depend on the absorbed doses delivered and not the activities administered. The field of molecular radiotherapy dosimetry has made considerable progress towards the feasibility of routine clinical dosimetry with reasonably accurate absorbed-dose estimates for a range of molecular radiotherapy dosimetry applications. A range of challenges remain with respect to the accurate quantification, assessment of time-integrated activity and absorbed dose estimation. In this review, we summarise a range of technological and methodological advancements, mainly focussed on beta-emitting molecular radiotherapeutics, that aim to improve molecular radiotherapy dosimetry to achieve accurate, reproducible, and streamlined dosimetry. We describe how these new technologies can potentially improve the often time-consuming considered process of dosimetry and provide suggestions as to what further developments might be required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Radiation Physics, Lund, Lund University, Lund, Sweden. Electronic address: johan_ruben.gustafsson@med.lu.se.
- National Radiotherapy Trials Quality Assurance (RTTQA) Group, Joint Department of Physics, Royal Marsden NHSFT, Downs Road, Sutton SM2 5PT, United Kingdom; The Institute of Cancer Research, 123 Old Brompton Road, London…
Förderung
- National Institute for Health and Care Research
- Institute of Cancer Research
- Swedish Cancer Society
- Fru Berta Kamprads Stiftelse
- Swedish Cancer Foundation
Zitieren
APA
Gustafsson, J., & Taprogge, J. (2023). Future trends for patient-specific dosimetry methodology in molecular radiotherapy. Physica Medica, 115, 103165. https://doi.org/10.1016/j.ejmp.2023.103165
Vancouver
Gustafsson J, Taprogge J. Future trends for patient-specific dosimetry methodology in molecular radiotherapy. Physica Medica. 2023;115:103165. doi:10.1016/j.ejmp.2023.103165
BibTeX
@article{Gustafsson2023,
author = {Gustafsson, Johan and Taprogge, Jan},
title = {Future trends for patient-specific dosimetry methodology in molecular radiotherapy},
journal = {Physica Medica},
year = {2023},
volume = {115},
pages = {103165},
doi = {10.1016/j.ejmp.2023.103165}
}
EUVIMED